HealthEquity, Inc. $HQY Position Lifted by Wasatch Advisors LP

Wasatch Advisors LP lifted its stake in HealthEquity, Inc. (NASDAQ:HQY) by 9.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,202,934 shares of the company’s stock after acquiring an additional 613,288 shares during the period. HealthEquity accounts for 4.0% of Wasatch Advisors LP’s portfolio, making the stock its largest position. Wasatch Advisors LP owned 0.09% of HealthEquity worth $601,949,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Geode Capital Management LLC boosted its position in HealthEquity by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 2,201,232 shares of the company’s stock valued at $201,685,000 after purchasing an additional 5,671 shares in the last quarter. Westfield Capital Management Co. LP raised its holdings in HealthEquity by 13.7% in the fourth quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock worth $178,864,000 after purchasing an additional 235,794 shares in the last quarter. William Blair Investment Management LLC bought a new position in HealthEquity in the fourth quarter worth about $169,956,000. AQR Capital Management LLC lifted its position in shares of HealthEquity by 59.3% during the third quarter. AQR Capital Management LLC now owns 1,764,268 shares of the company’s stock valued at $167,200,000 after buying an additional 656,820 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in shares of HealthEquity by 1.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,581,752 shares of the company’s stock valued at $144,911,000 after buying an additional 22,744 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of recent analyst reports. BMO Capital Markets upgraded shares of HealthEquity from a “market perform” rating to an “outperform” rating and raised their price target for the company from $85.00 to $105.00 in a report on Thursday, April 9th. KeyCorp reissued an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. JPMorgan Chase & Co. decreased their target price on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a research report on Wednesday, March 18th. Deutsche Bank Aktiengesellschaft raised their target price on shares of HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research note on Thursday, March 19th. Finally, Wells Fargo & Company set a $111.00 price target on shares of HealthEquity in a report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and a consensus target price of $110.57.

Insider Buying and Selling

In other HealthEquity news, EVP Delano Ladd sold 7,500 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the transaction, the executive vice president directly owned 91,141 shares of the company’s stock, valued at approximately $8,202,690. This trade represents a 7.60% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the sale, the director owned 19,733 shares of the company’s stock, valued at approximately $1,775,970. The trade was a 11.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 13,081 shares of company stock worth $1,193,000. 1.60% of the stock is owned by company insiders.

HealthEquity Stock Up 6.0%

HealthEquity stock opened at $88.46 on Friday. The business’s 50-day simple moving average is $85.30 and its two-hundred day simple moving average is $84.77. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The company has a market cap of $7.40 billion, a PE ratio of 33.13, a PEG ratio of 1.40 and a beta of 0.21. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $106.60.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities analysts anticipate that HealthEquity, Inc. will post 3.92 EPS for the current year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.